Chordoma dedifferentiation after proton beam therapy: a case report and review of the literature

J Med Case Rep. 2016 Oct 12;10(1):280. doi: 10.1186/s13256-016-1076-3.

Abstract

Background: Chordoma is a rare invasive bone tumor that may occur anywhere along the neuraxis. A total of three primary histological varieties have been identified: conventional, chondroid, and dedifferentiated.

Case presentation: We report a case of an 8-year-old white girl who presented with conventional chordoma, was treated with surgical resection and mixed proton and photon beam therapy, and had a recurrence in the resection cavity 2.5 years later with dedifferentiated morphology. The recurrent tumor did not express brachyury, a recently identified protein specific to tissue of notochordal origin.

Conclusions: The short time period between radiation therapy and dedifferentiation, low dose of photons, and rarity of dedifferentiated skull base chordomas in pediatric patients should alert clinicians to the possibility of chordoma dedifferentiation after proton beam therapy.

Keywords: Case report; Chordoma; Dedifferentiation; Oncology; Pediatric tumors; Proton beam therapy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Biomarkers, Tumor
  • Cell Dedifferentiation / physiology
  • Cell Dedifferentiation / radiation effects*
  • Cell Line, Tumor
  • Child
  • Chordoma / diagnostic imaging
  • Chordoma / pathology*
  • Chordoma / therapy
  • Female
  • Humans
  • Magnetic Resonance Imaging*
  • Neoplasm Recurrence, Local / pathology*
  • Neoplasm Recurrence, Local / surgery
  • Proton Therapy*
  • Radiation Dosage
  • Radiotherapy, Adjuvant*
  • Sarcoma / diagnostic imaging*
  • Sarcoma / pathology
  • Skull Base Neoplasms / diagnostic imaging
  • Skull Base Neoplasms / pathology*
  • Skull Base Neoplasms / therapy

Substances

  • Biomarkers, Tumor